The Role of the SLC Transporters in the Neurodegenerative Disorders
Asli Aykac 1, Ahmet Özer Şehirli 2*
1Near East University, Faculty of Medicine, Department of Biophysics, 2Near East University, Faculty of Dentistry, Department of Pharmacology,
Received: October 4, 2019; Revised: November 5, 2019; Accepted: November 6, 2019; Published online: November 6, 2019.
© The Korean College of Neuropsychopharmacology. All rights reserved.

Abstract
The solute carrier superfamily is one of the major sub-groups of membrane proteins in mammalian cells. The solute carrier proteins include more than 400 different membrane-spanning solute carriers organized with 65 families in the human. In solute carrier family neurons, the neurotransmitter is considered to be a pharmacological target of neuropsychiatric drugs because of their important role in the recovery of neurotransmitters such as GABA, glutamate, serotonin, dopamine and noradrenaline and regulation of their concentration in synaptic regions. Therefore, solute carrier transporters play vital and different roles in neurodegenerative disorders. In this article, the role of solute carrier transporters in neurodegenerative disorders such as Alzheimer Disease, Amyotrophic Lateral Sclerosis, Huntington Disease, Parkinson's Diseases, Depression, Post-Traumatic Stress Disorder, Dementia, Schizophrenia, and Epilepsy reviewed and discussed to see how defects or absences in solute carrier transporter cause neurodegenerative disorders. In this review, we try to summarize what is known about solute carriers with respect to brain distribution and expression. The review summarizes current knowledge on the roles of solute carrier transporters in neurodegenerative disorders.
Keywords: Solute carrier proteins, Amyotrophic Lateral Sclerosis, Alzheimer Disease, Post-traumatic disorder, Stress


e-submission

Archives